Robinetinidol-(4alpha->8)-catechin-(6->4alpha)-robinetinidol

Details

Top
Internal ID ac6ca1f8-7599-4a7e-aea4-84f7955ae9e7
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Biflavonoids and polyflavonoids
IUPAC Name (2R,3S)-2-(3,4-dihydroxyphenyl)-6,8-bis[(2R,3S,4S)-3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol
SMILES (Canonical) C1C(C(OC2=C(C(=C(C(=C21)O)C3C(C(OC4=C3C=CC(=C4)O)C5=CC(=C(C(=C5)O)O)O)O)O)C6C(C(OC7=C6C=CC(=C7)O)C8=CC(=C(C(=C8)O)O)O)O)C9=CC(=C(C=C9)O)O)O
SMILES (Isomeric) C1[C@@H]([C@H](OC2=C(C(=C(C(=C21)O)[C@H]3[C@@H]([C@H](OC4=C3C=CC(=C4)O)C5=CC(=C(C(=C5)O)O)O)O)O)[C@H]6[C@@H]([C@H](OC7=C6C=CC(=C7)O)C8=CC(=C(C(=C8)O)O)O)O)C9=CC(=C(C=C9)O)O)O
InChI InChI=1S/C45H38O18/c46-18-2-4-20-30(12-18)61-43(16-8-25(50)37(56)26(51)9-16)40(59)32(20)34-36(55)22-14-29(54)42(15-1-6-23(48)24(49)7-15)63-45(22)35(39(34)58)33-21-5-3-19(47)13-31(21)62-44(41(33)60)17-10-27(52)38(57)28(53)11-17/h1-13,29,32-33,40-44,46-60H,14H2/t29-,32-,33-,40-,41-,42+,43+,44+/m0/s1
InChI Key QZNRDKYJASOYMZ-BLBVDZAISA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C45H38O18
Molecular Weight 866.80 g/mol
Exact Mass 866.20581436 g/mol
Topological Polar Surface Area (TPSA) 331.00 Ų
XlogP 3.30
Atomic LogP (AlogP) 4.44
H-Bond Acceptor 18
H-Bond Donor 15
Rotatable Bonds 5

Synonyms

Top
85820-29-7
(2R,3S)-2-(3,4-dihydroxyphenyl)-6,8-bis[(2R,3S,4S)-3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol
CHEBI:8877
DTXSID60331908
Q27108167

2D Structure

Top
2D Structure of Robinetinidol-(4alpha->8)-catechin-(6->4alpha)-robinetinidol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8698 86.98%
Caco-2 - 0.8930 89.30%
Blood Brain Barrier - 0.7000 70.00%
Human oral bioavailability - 0.8000 80.00%
Subcellular localzation Mitochondria 0.4793 47.93%
OATP2B1 inhibitior - 0.7084 70.84%
OATP1B1 inhibitior + 0.9203 92.03%
OATP1B3 inhibitior + 0.9459 94.59%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.8622 86.22%
P-glycoprotein inhibitior + 0.7072 70.72%
P-glycoprotein substrate - 0.6286 62.86%
CYP3A4 substrate + 0.6251 62.51%
CYP2C9 substrate - 0.5994 59.94%
CYP2D6 substrate + 0.5264 52.64%
CYP3A4 inhibition - 0.8309 83.09%
CYP2C9 inhibition - 0.9071 90.71%
CYP2C19 inhibition - 0.9026 90.26%
CYP2D6 inhibition - 0.9231 92.31%
CYP1A2 inhibition - 0.9155 91.55%
CYP2C8 inhibition + 0.7913 79.13%
CYP inhibitory promiscuity - 0.8625 86.25%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.6139 61.39%
Eye corrosion - 0.9904 99.04%
Eye irritation - 0.8798 87.98%
Skin irritation - 0.6044 60.44%
Skin corrosion - 0.9317 93.17%
Ames mutagenesis + 0.6700 67.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8747 87.47%
Micronuclear + 0.7859 78.59%
Hepatotoxicity - 0.6500 65.00%
skin sensitisation - 0.7665 76.65%
Respiratory toxicity + 0.7333 73.33%
Reproductive toxicity + 0.8000 80.00%
Mitochondrial toxicity + 0.6000 60.00%
Nephrotoxicity - 0.8531 85.31%
Acute Oral Toxicity (c) IV 0.5696 56.96%
Estrogen receptor binding + 0.7770 77.70%
Androgen receptor binding + 0.7555 75.55%
Thyroid receptor binding + 0.5936 59.36%
Glucocorticoid receptor binding - 0.5000 50.00%
Aromatase binding + 0.5192 51.92%
PPAR gamma + 0.7275 72.75%
Honey bee toxicity - 0.7863 78.63%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity + 0.6000 60.00%
Fish aquatic toxicity + 0.6855 68.55%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.71% 91.11%
CHEMBL1951 P21397 Monoamine oxidase A 96.98% 91.49%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.42% 96.09%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 94.07% 99.15%
CHEMBL3137262 O60341 LSD1/CoREST complex 93.11% 97.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 90.60% 89.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.58% 95.56%
CHEMBL3227 P41594 Metabotropic glutamate receptor 5 88.16% 96.42%
CHEMBL2535 P11166 Glucose transporter 87.68% 98.75%
CHEMBL236 P41143 Delta opioid receptor 86.91% 99.35%
CHEMBL2041 P07949 Tyrosine-protein kinase receptor RET 86.76% 91.79%
CHEMBL3401 O75469 Pregnane X receptor 86.58% 94.73%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 86.38% 94.45%
CHEMBL217 P14416 Dopamine D2 receptor 86.26% 95.62%
CHEMBL3194 P02766 Transthyretin 86.15% 90.71%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 85.50% 85.14%
CHEMBL2581 P07339 Cathepsin D 85.16% 98.95%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.77% 95.89%
CHEMBL3438 Q05513 Protein kinase C zeta 84.10% 88.48%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 81.97% 99.23%
CHEMBL1293249 Q13887 Kruppel-like factor 5 80.66% 86.33%
CHEMBL1994 P08235 Mineralocorticoid receptor 80.59% 100.00%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 80.39% 93.40%

Cross-Links

Top
PubChem 442689
NPASS NPC159147